Myeloid cells functioning in tumor vascularization as a novel therapeutic target (Q37059331)

18 August 2017

1 reference

title

Myeloid cells functioning in tumor vascularization as a novel therapeutic target (English)

1 reference

18 August 2017

Karen McLean

1

1 reference

PubMed ID

18201673

18 August 2017

Ronald J Buckanovich

series ordinal

2

1 reference

18 August 2017

26 December 2007

1 reference

18 August 2017

Translational Research

1 reference

18 August 2017

151

1 reference

18 August 2017

2

1 reference

18 August 2017

59-67

1 reference

Angiogenesis in life, disease and medicine

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Tumor angiogenesis: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Tumorigenesis and the angiogenic switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Regulation of angiogenesis by the hemostatic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Role of angiogenesis in tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Essential role of stromally induced hedgehog signaling in B-cell malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Monocyte/macrophage infiltration in tumors: modulators of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Distinct role of macrophages in different tumor microenvironments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Mast cells and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Endothelial differentiation potential of human monocyte-derived multipotential cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

A human peripheral blood monocyte-derived subset acts as pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Vascular leukocytes contribute to tumor vascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

In vitro transformation of monocytes and dendritic cells into endothelial like cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Monocytes form a vascular barrier and participate in vessel repair after brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

CD34- blood-derived human endothelial cell progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Splenic endothelial cell lines support development of dendritic cells from bone marrow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Tumor skewing of CD34+ cell differentiation from a dendritic cell pathway into endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

The role of dendritic cell precursors in tumour vasculogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Cutting edge: proangiogenic properties of alternatively activated dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Altered macrophage differentiation and immune dysfunction in tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Role of tumor-associated macrophages in tumor progression and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Antiangiogenic therapy: a universal chemosensitization strategy for cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Treatment options in metastatic renal carcinoma: an embarrassment of riches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

The vascular disrupting agent, DMXAA, directly activates dendritic cells through a MyD88-independent mechanism and generates antitumor cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Tumor vascular proteins as biomarkers in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Genes that distinguish physiological and pathological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Adiponectin promotes endothelial cell differentiation from human peripheral CD14+ monocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Transplanted human bone marrow contributes to vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

The bone marrow constitutes a reservoir of pericyte progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.11.002

10.1016/J.TRSL.2007.11.002

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18201673